Work

Programmed death ligand-1 (PDL1) and CD3 co-expression in patients with advanced stage EGFR mutant NSCLC treated with EGFR tyrosine kinase inhibitors (TKI)

Year: 2015

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1093/annonc/mdv513.10

Authors: R.A. Soo, H.R. Kim, B.R. Asuncion, Z. Fazreen, M.F.M. Omar, M.C. Herrera, J.S.Y. Lim, G. Sia, R. Soong, B.-C. Cho

Institutions: National University Cancer Institute, Singapore, Yonsei University, Yonsei Cancer Hospital, National University of Singapore, Cancer Science Institute of Singapore

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2273208817

FWCI:

Cites:

Cited by:

Related to: 10